Duality Advisers’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-49,322
| Closed | -$1.43M | – | 416 |
|
|
2024
Q1 | $1.43M | Buy |
49,322
+2,724
| +6% | +$79.2K | 0.14% | 246 |
|
|
2023
Q4 | $1.28M | Buy |
46,598
+10,625
| +30% | +$293K | 0.14% | 262 |
|
|
2023
Q3 | $806K | Buy |
35,973
+145
| +0.4% | +$3.25K | 0.1% | 335 |
|
|
2023
Q2 | $1.46M | Buy |
35,828
+25,800
| +257% | +$1.05M | 0.18% | 217 |
|
|
2023
Q1 | $486K | Sell |
10,028
-23,432
| -70% | -$1.14M | 0.06% | 415 |
|
|
2022
Q4 | $1.28M | Sell |
33,460
-1,697
| -5% | -$64.8K | 0.15% | 254 |
|
|
2022
Q3 | $1.77M | Buy |
+35,157
| New | +$1.77M | 0.19% | 212 |
|
|
2022
Q2 | – | Sell |
-22,330
| Closed | -$833K | – | 816 |
|
|
2022
Q1 | $833K | Buy |
22,330
+14,607
| +189% | +$545K | 0.09% | 370 |
|
|
2021
Q4 | $308K | Sell |
7,723
-18,197
| -70% | -$726K | 0.03% | 443 |
|
|
2021
Q3 | $964K | Buy |
25,920
+16,809
| +184% | +$625K | 0.07% | 361 |
|
|
2021
Q2 | $385K | Sell |
9,111
-45,839
| -83% | -$1.94M | 0.03% | 455 |
|
|
2021
Q1 | $2.6M | Buy |
54,950
+33,316
| +154% | +$1.58M | 0.23% | 146 |
|
|
2020
Q4 | $1.32M | Buy |
21,634
+574
| +3% | +$35K | 0.1% | 296 |
|
|
2020
Q3 | $985K | Buy |
+21,060
| New | +$985K | 0.06% | 373 |
|